Adverse drug reaction

Clinical Experience

Enhancing Patient Safety: The Vital Role of the Care Team in Reporting Adverse Drug Events

01/15/2025

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Jen Devinney-Lavsa , BPharm, PharmD, FASCP;

Adverse drug events (ADEs) can significantly affect patients, especially in long-term care (LTC) settings, where frailty and polypharmacy increase vulnerability. This article emphasizes the importance of ADE reporting as a critical aspect of...

Adverse drug events (ADEs) can...

01/15/2025

Annals of Long-Term Care

Practical Research

High Utilization of CYP2D6 Substrate Prescriptions Among Long-Term Care Residents With Overactive Bladder

10/07/2022

Jason Yeaw , MPH;

Adam Carrera , PharmD;

Paul N. Mudd Jr., PharmD, MBA;

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

John R. Horn , PharmD;

Noelia Goti , BS;

Stacie Holland , PharmD;

Drishti Shah , PhD;

This study aims to describe the prevalence of CYP2D6 substrate use among LTC residents with OAB and among a subset of residents with OAB receiving mirabegron.

This study aims to describe the...

10/07/2022

Annals of Long-Term Care